Skip to content

Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status.

Randomized controlled trial · Food Funct · 2022. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 35621073

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Nano-curcumin supplementation in critically ill patients with sepsis: a randomized clinical trial investigating the inflammatory biomarkers, oxidative stress indices, endothelial function, clinical outcomes and nutritional status.

Karimi A, Naeini F, Niazkar HR et al.
Food Funct · 2022

PubMed ID
35621073
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.